Sue Marshall blogs about diabetes for Desang

NICE Released Their Preliminary Recommendation On The Use Of Liraglutide For Patients With Type 2 Diabetes | March 23, 2010

NICE preliminary recommendations on the use of a once-daily injection for type 2 diabetics have been released, and so far results are positive.

Victoza (liraglutide) is a once-daily injectable human GLP-1 analogue licensed in Europe, the US and Japan and available in the UK since July 2009 for people with type 2 diabetes in combination with oral anti-diabetic tablets.*

Today, NICE released their preliminary recommendation on the use of liraglutide for patients with type 2 diabetes. Final guidance is expected mid 2010.

The preliminary recommendation positions once-daily liraglutide 1.2 mg as a clinically and cost effective treatment option, for use in combination with two oral anti-diabetic tablets for the treatment of people with type 2 diabetes and a Body Mass Index (BMI) above 35 in the general population. In addition it may be used in certain patient types with a BMI below 35.

NICE has asked for further information to support the general use of liraglutide in combination with only one anti-diabetic tablet. Novo Nordisk are confident that we can provide the information requested and answer any further questions that may follow to support a recommendation in this group of patients.

In the current draft guidance NICE does not recommend the liraglutide 1.8 mg dose. Novo Nordisk believes there are significant benefits of this dose in particular patient groups and we will be discussing this with NICE.

Viggo Birch, Managing Director, Novo Nordisk Limited says “We are very encouraged by the preliminary recommendation from NICE regarding the use of liraglutide 1.2 mg and that NICE have seen the value of liraglutide and the major benefits that it has for patients with type 2 diabetes. We look forward to the next stage of discussions with NICE and the resulting guidance expected around June, which we hope will mirror the license we were awarded in July 2009 by the European Medicines Agency (EMA formerly EMEA).”



Posted in diabetes

Leave a Comment »

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

    Search Sue Marshall’s blog

    Desang Diabetes Directory

    See our directory of diabetes management kit -- blood test machines, insulin delivery devices, finger-prickers.

    Sue Marshall picture

    Sue Marshall

%d bloggers like this: